Pigmentation abnormalities in nucleotide excision repair disorders: Evidence and hypotheses.


Journal

Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927

Informations de publication

Date de publication:
01 2019
Historique:
received: 02 03 2018
revised: 11 05 2018
accepted: 11 06 2018
pubmed: 26 6 2018
medline: 16 4 2019
entrez: 26 6 2018
Statut: ppublish

Résumé

Skin pigmentation abnormalities are manifested in several disorders associated with deficient DNA repair mechanisms such as nucleotide excision repair (NER) and double-strand break (DSB) diseases, a topic that has not received much attention up to now. Hereditary disorders associated with defective DNA repair are valuable models for understanding mechanisms that lead to hypo- and hyperpigmentation. Owing to the UV-associated nature of abnormal pigmentary manifestations, the outcome of the activated DNA damage response (DDR) network could be the effector signal for alterations in pigmentation, ultimately manifesting as pigmentary abnormalities in repair-deficient disorders. In this review, the role of the DDR network in the manifestation of pigmentary abnormalities in NER and DSB disorders is discussed with a special emphasis on NER disorders.

Identifiants

pubmed: 29938913
doi: 10.1111/pcmr.12720
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-40

Subventions

Organisme : Association Nationale de la Recherche et de la Technologie
ID : 1105/2014
Pays : International

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Zeinab Kasraian (Z)

NAOS, Aix en Provence, France.
Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.

Sandra Trompezinski (S)

NAOS, Aix en Provence, France.

Muriel Cario-André (M)

Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.
Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France.

Fanny Morice-Picard (F)

Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France.
Service de Dermatologie Adulte et Pédiatrique, CHU de Bordeaux, Bordeaux, France.

Cécile Ged (C)

Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.
Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France.

Marie-Laure Jullie (ML)

Department of Pathology, CHU de Bordeaux, Bordeaux, France.

Alain Taieb (A)

Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.
Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France.
Service de Dermatologie Adulte et Pédiatrique, CHU de Bordeaux, Bordeaux, France.

Hamid Reza Rezvani (HR)

Univ. Bordeaux, Inserm, BMGIC, UMR 1035, Bordeaux, France.
Centre de Référence pour les Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH